コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 id, or in cells treated with an inhibitor of lysosomal acid lipase.
2 ined a sequence derived from the propiece of lysosomal acid lipase.
4 These studies indicate that administrated lysosomal acid lipase affects the atherogenesis by at le
6 not be labeled by commercial probes, such as lysosomal acid lipase and cytosolic phospholipase A2.
7 nriched, as we have previously described, in lysosomal acid lipase and glucocerebrosidase, and locali
8 fic lysosomal signaling mediated by a LIPL-4 lysosomal acid lipase and its lipid chaperone LBP-8 incr
10 ction: (a) LDL-CE hydrolysis is catalyzed by lysosomal acid lipase; (b) neither scavenger receptors n
12 n-triggered cell growth and emphysema during lysosomal acid lipase deficiency are partially caused by
14 ongation, or desaturation in contrast to the lysosomal acid lipase deficiency found in Wolman disease
16 lacement therapy in children and adults with lysosomal acid lipase deficiency, an underappreciated ca
17 including Fabry's disease, Pompe's disease, lysosomal acid lipase deficiency, and five types of muco
18 of fatty liver, such as HIV, lipodystrophy, lysosomal acid lipase deficiency, familial hypobetalipop
23 esteryl ester and triglyceride metabolism in lysosomal acid lipase gene knockout mice (lal-/-) result
24 nsgenic system was used to reintroduce human lysosomal acid lipase (hLAL) expression into LAL gene kn
25 t on protein kinase C-mediated activation of lysosomal acid lipase in Wnt4-deficient bone marrow-deri
26 r the NPC1 or NPC2 protein in NPC disease or lysosomal acid lipase in Wolman disease results in defec
43 eptor CD36 and their subsequent lipolysis by lysosomal acid lipase (LAL) was important for the engage
45 cyte fat mobilization, the metabolic role of lysosomal acid lipase (LAL), highly expressed in adipocy
46 e disease (CESD), an inherited deficiency of lysosomal acid lipase (LAL), is an underappreciated caus
49 e studied the effect of lalistat, a specific lysosomal acid lipase (LAL/Lipa) inhibitor on LD degrada
51 ion caused by mutations in the gene encoding lysosomal acid lipase (LIPA) that result in reduced or a
52 red for the maintenance of AT; deficiency in lysosomal acid lipase (Lipa), the enzyme required for ly
53 explant culture, establishing dependency on lysosomal acid lipase (LIPA/LAL) and the microphthalmia/
55 ulated in mice, genomic clones for the mouse lysosomal acid lipase (mLAL) gene were isolated and char
58 c expression of the lysosomal hydrolase LAL (lysosomal acid lipase) to mobilize FA for FAO and memory
59 Compared with sham-treated mice, the human lysosomal acid lipase-treated mice also have reduced lev
61 essing that involves two lysosomal proteins, lysosomal acid lipase, which hydrolyzes C esters, and NP